Donepezil for mild cognitive impairment in Parkinson’s disease

Donepezil for mild cognitive impairment in Parkinson’s disease

Abstract We investigated the efficacy of donepezil for mild cognitive impairment in Parkinson’s disease (PD-MCI). This was a prospective, non-randomized, open-label, two-arm study. Eighty PD-MCI patients were assigned to either a treatment or control group. The treatment group received donepezil for...

Full description

Bibliographic Details
Main Authors: Kyoungwon Baik, Seon Myeong Kim, Jin Ho Jung, Yang Hyun Lee, Seok Jong Chung, Han Soo Yoo, Byoung Seok Ye, Phil Hyu Lee, Young H. Sohn, Seung Wan Kang, Suk Yun Kang
Format: Article
Language:English
Published: Nature Publishing Group 2021-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-84243-4

Internet

https://doi.org/10.1038/s41598-021-84243-4

Similar Items